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Subclinical Atherosclerosis and Obesity Phenotypes Among Mexican
Americans
Susan T. Laing, MD, MSc; Beverly Smulevitz, BS; Kristina P. Vatcheva, MS; Mohammad H. Rahbar, PhD; Belinda Reininger, DrPH;
David D. McPherson, MD; Joseph B. McCormick, MD; Susan P. Fisher-Hoch, MD
Background-—Data on the influence of obesity on atherosclerosis in Hispanics are inconsistent, possibly related to varying
cardiometabolic risk among obese individuals. We aimed to determine the association of obesity and cardiometabolic risk with
subclinical atherosclerosis in Mexican-Americans.
Methods and Results-—Participants (n=503) were drawn from the Cameron County Hispanic Cohort. Metabolic health was defined
as <2 of the following: blood pressure ≥130/85; triglyceride ≥150 mg/dL; high-density lipoprotein cholesterol <40 mg/dL (men)
or <50 mg/dL (women); fasting glucose ≥100 mg/dL; homeostasis model assessment of insulin resistance value >5.13; or high-
sensitivity C-reactive protein >3 mg/L. Carotid intima media thickness (cIMT) was measured. A high proportion of participants
(77.8%) were metabolically unhealthy; they were more likely to be male, older, with fewer years of education, and less likely to meet
daily recommendations regarding fruit and vegetable servings. One-third (31.8%) had abnormal carotid ultrasound findings. After
adjusting for covariates, mean cIMT varied across the obesity phenotypes (P=0.0001); there was no difference among the
metabolically unhealthy regardless of whether they were obese or not. In multivariable analysis, after adjusting for covariates,
cardiometabolic risk (P=0.0159), but not obesity (P=0.1446), was significantly associated with subclinical atherosclerosis.
Conclusions-—In Mexican-Americans, cardiometabolic risk has a greater effect on early atherosclerosis development than body
mass index. Non-obese but metabolically unhealthy participants had similar development of subclinical atherosclerosis as their
obese counterparts. Interventions to maintain metabolic health among obese and non-obese patients may be a more important
goal than weight loss alone. ( J Am Heart Assoc. 2015;4:e001540 doi: 10.1161/JAHA.114.001540)
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O besity has been increasing in epidemic proportions overthe past decades particularly in ethnic minority
groups.1,2 Recently, there have been reports that this obesity
trend may be levelling off in the United States,3 but that there
is a disturbing ethnic disparity with a slower decline in non-
Hispanic blacks and an increase in Mexican-Americans
compared with non-Hispanic whites.4 Obesity has an adverse
impact on most of the cardiovascular (CV) risk factors5 with a
shift in the incidence of these risk factors to a younger age.6
Obesity is thought to affect CV events through adverse
remodeling of the large arteries, and a higher prevalence of
subclinical vascular disease has been shown among those
who are obese compared with those who are not.7,8 However,
the influence of obesity on CV mortality is not as clear, and
substantial data have been published over recent years
demonstrating better prognosis in some obese patients
compared with their leaner counterparts with the same CV
disease (CVD).9,10 This discrepancy may be related to varying
cardiometabolic profiles among obese individuals, which may
have a more important effect on cardiovascular risk than
obesity. Indeed the concept of “metabolically healthy” obesity
has been studied and several investigators have recently
shown that coronary heart disease may not be increased in
this obesity phenotype.11,12
Mexican-Americans have very high prevalence of obesity
compared with non-Hispanic whites. Data on CVD in Mexican-
Americans are likewise conflicting and despite the very high
obesity prevalence, reported CV death rates are no higher
than in whites.13 With the changing landscape of ethnic
diversity in the United States, it is important to understand CV
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risk in distinct racial cohorts. We hypothesize that cardio-
metabolic risk has a greater effect on early atherosclerosis
development than obesity in Mexican-Americans and that the
influence of cardiometabolic risk is more important than body
mass index (BMI) alone. This study aimed to determine the
association of subclinical atherosclerosis to obesity and




This study was approved by the Institutional Review Board of
the University of Texas Health Science Center-Houston and all
participants gave written informed consent. Study partici-
pants were a subset of the Cameron County Hispanic Cohort
(CCHC) (n=503), recruited from randomly selected blocks
according to the 2000 Census as described previously.14 The
CCHC is a homogenous community-dwelling Mexican-Amer-
ican cohort living in Brownsville (Cameron County), Texas, a
city on the lower Rio Grande River at the United States-
Mexico border.
Extensive family, socioeconomic, educational, and personal
medical histories, as well as physical activity and dietary
histories, were obtained using a directed questionnaire.
Surveys and data collection were conducted in the partici-
pants’ language of preference (Spanish or English) by bilingual
research nurses and field workers. Physical activity was
assessed using the International Physical Activity Question-
naire short-form (IPAQ);15 reported minutes of physical
activity per week were weighted by a metabolic equivalent
(MET; multiples of resting energy expenditure) resulting in a
physical activity estimate expressed as MET-minutes per
week.15 Participants were asked to fast for at least 10 hours
overnight before a visit to the Clinical Research Unit.
Anthropometric measurements obtained included height,
weight, and waist circumference. Waist circumference (vis-
ceral adiposity) was measured at the level of the umbilicus to
the nearest 0.2 cm, with the subject in a standing position
and breathing normally. Height was measured to the nearest
0.2 cm using a stadiometer. BMI was calculated as weight in
kilograms divided by height squared in meters (kg/m2). The
average of 3 blood pressure (BP) and HR readings taken
5 minutes apart were used. Laboratory studies performed
included fasting lipid panel, hemoglobin (Hb) A1c, fasting
plasma glucose, and fasting serum insulin. Homeostasis
model assessment insulin resistance index (HOMA-IR) was
calculated as fasting glucose (mg/dL)/189 fasting insulin
(mU/L)/22.5.16 High-sensitivity C-reactive protein (hsCRP)
levels were measured using a high-sensitivity immunoassay
(Dimension Vista 1500; Siemens Corporation, Washington,
DC). High-sensitivity CRP levels >10 mg/L were excluded
from analysis as such high levels likely represent acute
illness.17
The presence of hypertension was both self-reported and
measured as described below. The subject was deemed to
be hypertensive if the mean systolic blood pressure (SBP)
was ≥140 mm Hg or the mean diastolic blood pressure
(DBP) was ≥90 mm Hg.18 Classification of diabetes was also
both self reported and based on measurement of HbA1c
(HbA1c>6.5%) as per the latest guidelines from the American
Diabetes Association.19 Smoking status was defined as an
affirmative answer to the question “Do you currently smoke
cigarettes?” BMI was categorized according to the National
Heart Lung and Blood Institute (NHLBI) with overweight
defined as a BMI ≥25.0 kg/m2 and obesity defined as a
BMI≥30.0 kg/m2. Morbid obesity was defined as a BMI
≥40.0 kg/m2.20
Obesity Phenotypes
Participants were categorized as obese or non-obese using a
BMI cutoff of ≥30.0 kg/m2 and then were further categorized
as metabolically healthy or unhealthy. Metabolic health was
defined as having <2 of the following cardiometabolic
abnormalities: SBP ≥130 mm Hg and/or DBP ≥85 mm Hg
or on antihypertensive medication; triglyceride ≥150 mg/dL;
high-density lipoprotein cholesterol <40 mg/dL in men or
<50 mg/dL in women; fasting glucose ≥100 mg/dL or on
hypoglycemic medication; HOMA-IR value >5.13; or hsCRP
>3 mg/L.21,22 Waist circumference was not included due to
its high correlation with BMI.23 To better assess the
inflammatory component of cardiometabolic risk, hsCRP
was added to our criteria of metabolic health, as has been
suggested by other investigators.21,22,24
Carotid Ultrasound Evaluation of Subclinical
Atherosclerosis
Carotid ultrasound studies to evaluate subclinical atheroscle-
rosis were performed using the Siemens Acuson X300
ultrasound system (Malvern, PA) using a VF 13-5 linear array
transducer. The protocol was designed following guidelines
from the American Society of Echocardiography consensus
statement on subclinical vascular disease.25 Both common
carotids were imaged from 3 different angles for a total of 6
images. Carotid plaque presence was determined by exam-
ining the carotid bulb, its bifurcation and the carotid branch
arteries in addition to the common carotid artery. Carotid IMT
was measured using the Carotid Analyzer software (Medical
Imaging Applications, Coralville, IA), a semi-automated border
detection program. Measurements were made at the R-wave
of the electrocardiogram on a minimum of 2 clips from each
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side and the results were averaged. Mean cIMT was
categorized as being either <or ≥75th percentile for age
and gender.25 Carotid plaque was defined as an area of wall
thickening that was >50% of the thickness of the surrounding
wall. Abnormal carotid ultrasound was then defined as a cIMT
≥75% for age and gender and/or presence of atherosclerotic
plaque. All measurements were performed by a single blinded
expert reader. Replicate readings were performed on 5% of
the cohort and the intraclass correlation coefficient for our
laboratory was 0.96.
Statistical Analysis
All analyses reported in this paper are adjusted for age and
gender using the sampling weights. In addition, the analyses
have taken into consideration clustering effects of multiple
participants from the same household as well as census
block.14 Data are summarized as weighted mean and
standard error for continuous variables and weighted
frequency and percentages for categorical variables. Partic-
ipant demographics were stratified by gender and evaluated
using univariable analysis. Cohort demographics and meta-
bolic characteristics were compared by obesity phenotype
groups and evaluated using univariable and multivariable
analyses. Specifically, for comparing continuous variables,
we applied survey-weighted linear regression models from
which Tukey-Kramer-adjusted P values were calculated and
used for multiple pairwise mean comparisons. For comparing
categorical variables, we applied survey-weighted logistic
regression to obtain the Rao-Scott F-adjusted chi-square P
values. Contingency coefficient was used to measure the
degree of relationship between abnormal carotid ultrasound
and obesity phenotypes. Multivariable survey-weighted
logistic regression analysis was performed to obtain the
weighted odds ratios (OR) and 95% confidence intervals (CI)
for abnormal carotid ultrasound by the obesity phenotype
groups. Initially, a multivariable survey-weighted linear
regression model was created to identify factors associated
with mean cIMT, among variables including the obesity
phenotypes, age, gender, SBP, diabetes status, lipids, CRP,
reported minutes of physical activity per week, servings
of fruits and vegetables per day, and smoking status.
Further analysis using a multivariable weighted linear
regression model was then performed to assess the effects
of cardiometabolic risk and obesity on mean cIMT, after
adjusting for significant confounders. Variables that were not
significant and were not confounders were excluded from
the final model. Two-way additive scale interaction effects
between each pair of independent variables were tested. All
statistical tests were two sided and conducted at 5% level of
significance, and all analyses were performed using SAS 9.2
(SAS Institute Inc., Cary, NC).
Results
Demographics and metabolic characteristics are listed in
Table 1. This is a relatively young cohort with a mean age of
50.40.95 years (range 18 to 85 years); 41% (n=159) were
male. There was a high prevalence of CV risk factors in this
cohort; 39% were hypertensive, 20.1% had diabetes, and
56.5% had dyslipidemia, with no gender differences in
prevalence. However, men were more likely to be smokers
than women (18.1% versus 6.7%, P<0.001). More than half of
the cohort participants were obese (52.5%) and there were
also no significant gender differences for the prevalence of
obesity in the cohort. The mean CRP was 3.50.2 mg/L,
which is considered to be in the high-risk category for
cardiovascular events,17 and there was no difference in CRP
levels between men and women. Only 32.2% of the cohort
met the minimum recommendations of ≥600 MET-minutes of
physical activity per week,26,27 and even less (12.5%) met the
American Heart Association (AHA) recommendations for
servings of fruit and vegetables per day,28 with no gender
differences for both variables. The mean duration of education
was 10.24.1 years. The median annual income was
$20 000. Only 43.4% of women were employed versus
73.7% of the men (P<0.0001). Among those women who were
employed, median annual income was significantly lower in
women compared with men (P=0.0008).
There was a high proportion (77.8%) of participants who
were classified as metabolically unhealthy (n=149 [29.7%] for
non-obese participants and n=250 [48.1%] for obese partic-
ipants; Table 1). Compared with those who were metabolically
healthy, those classified as metabolically unhealthy were
more likely to be male (44.4% versus 29.2%, P=0.029), were
older (51.40.9 years versus 46.32.3 years, P=0.0325),
had larger waist circumference (106.91.14 cm versus
93.81.1 cm, P<0.0001), and had fewer years of education
(10.30.3 years versus 12.10.5 years, P=0.0017). They
were also less likely to meet the recommended guidelines for
eating 5 or more servings of fruits and vegetables per day
(8.6% versus 24.4%, P<0.0046) compared with those who
were metabolically healthy.
Nearly one-third of the cohort (29.7%) was classified as
metabolically unhealthy non-obese. Among the non-obese
participants, those who were classified as metabolically
unhealthy were also more likely to be male (48.8% versus
29.1%, P=0.026), were older (53.21.4 years versus
46.72.7 years, P=0.028), had larger waist circumference
(96.50.8 cm versus 91.11.0 cm, P<0.0001), and had fewer
years of education (10.00.4 years versus 12.20.6 years,
P=0.003) compared with the metabolically healthy. They were
also less likely to meet the recommended servings of fruits and
vegetables per day (6.8% for unhealthy non-obese versus 21.5%
for healthy non-obese, P=0.019). In this cohort, among the
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obese participants, only 4.4% (n=25) were classified as
metabolically healthy. In contrast to the non-obese participants,
age and gender were not different among the metabolically
healthy or unhealthy obese. Obese metabolically unhealthy
participants had similarly larger waist circumference
(113.31.4 cm versus 105.01.8 cm, P=0.0002) and were
less likely to meet the recommended servings of fruits and
vegetables per day (9.6% for unhealthy obese versus 37.4% for
healthy obese, P=0.0065). In contrast to the non-obese
participants however, hsCRP levels were different between
themetabolically healthy and unhealthy obese participants with
the metabolically unhealthy obese more likely to have elevated
hsCRP levels (≥3 mg/L) than their metabolically healthy
counterparts (85.1% versus 52.4%, P=0.0009).
Table 1. Cohort Demographics and Metabolic Characteristics
Total
Metabolically Healthy Metabolically Unhealthy
P Value
Healthy Non-Obese Healthy Obese Unhealthy Non-Obese Unhealthy Obese
n=503 n=79 (17.8%) n=25 (4.4%) n=149 (29.7%) n=250 (48.1%)
Categorical variables, n (%)
Men 159 (41.0) 24 (29.1) 6 (29.7) 59 (48.8) 70 (41.7) 0.1063
Employed 261 (55.8) 52 (63.8) 19 (74.5) 72 (50.3) 118 (54.6) 0.2147
Met minimum recommendations
for physical activity of ≥600
MET-minutes/week
123 (32.2) 29 (44.7) 8 (35.4) 41 (37.2) 45 (23.9) 0.0625
Met recommendations
of ≥5 servings of fruit and
vegetables per day
45 (12.5) 11 (21.5) 6 (37.4) 10 (6.8) 18 (9.6) 0.0071
Current smokers 41 (11.3) 8 (10.3) 1 (2.5) 11 (11.7) 21 (12.2) 0.4845
Diabetes (ADA2010_DM variable) 108 (20.1) 0 (0) 0 (0) 32 (20.1) 76 (29.2) 0.1188
CRP≥3 mg/L 335 (71.3) 28 (50.4) 10 (52.4) 93 (64.5) 204 (85.1) <0.0001
Continuous variables, meanSE
Age, y 50.30.9 46.72.7 44.83.4 53.21.4 50.31.2 0.0421
Annual household
income (US dollars)
354253664.2 4355612153.0 319215571.5 299054978.3 354514270.5 0.6791




901.2179.6 1212.7295.4 4148.03481.4 806.3148.0 519.3114.8 0.075
Total cholesterol, mg/dL 182.72.3 184.06.5 187.68.1 181.34.0 182.63.1 0.8471
Triglycerides, mg/dL 153.45.6 86.15.6 89.76.9 172.011.0 172.77.4 <0.0001
HDL-cholesterol, mg/dL 44.80.9 55.31.5 54.02.9 42.92.3 41.20.9 <0.0001
LDL-cholesterol, mg/dL 107.91.9 112.15 114.85.8 105.03.4 107.62.8 0.4184
BMI, kg/m2 31.30.4 25.90.3 33.20.6 26.80.2 35.80.6 <0.0001
Waist circumference, cm 104.01.0 91.11.0 104.91.8 96.50.8 113.31.4 <0.0001
Systolic blood pressure, mm Hg 118.10.9 109.91.5 108.82.4 119.91.7 120.91.4 <0.0001
Diastolic blood pressure, mm Hg 72.30.6 67.01.4 69.01.6 72.40.9 74.50.9 0.0007
CRP, mg/L* 3.50.2 2.40.4 3.50.3 2.10.4 4.30.3 <0.0001
Insulin, mg/dL 15.31.1 8.30.6 11.50.9 14.22.0 19.21.8 <0.0001
Fasting blood glucose, mg/dL 107.21.9 91.30.9 95.61.9 108.53.8 113.32.7 <0.0001
HOMA IR 4.00.3 1.80.1 2.70.2 3.60.4 5.30.5 <0.0001
Hba1c, % 5.60.1 5.10.1 5.20.2 5.60.1 5.90.1 <0.0001
Data are adjusted for the probability of sampling using weights taking into consideration clustering effects arising from the same census block and household. BMI indicates body mass
index; CRP, C-reactive protein; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment insulin resistance index; LDL, low-density lipoprotein; MAT, metabolic equivalent.
*CRP>10 mg/L excluded, n=283.
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The mean cIMT for the cohort was 0.670.01 mm, with
men having thicker mean cIMT than women (0.690.02 mm
in men versus 0.650.01 mm in women; P=0.0228; Table 2).
Age was highly correlated with cIMT (r=0.59, P<0.0001).
One-third of the cohort (31.8%) had abnormal carotid
ultrasound findings defined as a cIMT ≥75% for age and
gender and/or presence of atherosclerotic plaque. Mean cIMT
varied across the 4 obesity phenotypes (P=0.0001). There
was no difference in mean cIMT between the obese and non-
obese metabolically healthy phenotypes (P=0.986). Similarly,
there was no difference in mean cIMT among those who were
classified as metabolically unhealthy regardless of whether
they were obese or not (P=1.00). In contrast, there was a
significant difference in mean cIMT between the obese
metabolically healthy and unhealthy phenotypes (P=0.038)
and the non-obese metabolically healthy and unhealthy
phenotypes (P=0.0024, Figure). The weighted odds ratio for
having an abnormal carotid ultrasound study was significantly
Table 2. Carotid Ultrasound Findings
Total
Metabolically Healthy Metabolically Unhealthy
P Value
Healthy Non-Obese Healthy Obese Unhealthy Non-Obese Unhealthy Obese
n=503 n=79 n=25 n=149 n=250
Categorical variables, n (%)
Mean cIMT ≥75% 85 (17.5) 2 (1.47) 3 (8.77) 29 (21.6) 51 (21.71) 0.0005
Presence of plaque 115 (24.2) 10 (15.27) 4 (16.69) 36 (24.34) 65 (28.11) 0.2502
Abnormal carotid study 156 (31.8) 11 (15.59) 6 (22.72) 50 (33.79) 89 (37.4) 0.0241
Continuous variables, meanSE
Mean cIMT, mm 0.670.01 0.600.02 0.610.02 0.680.02 0.680.02 0.0001
cIMT indicates carotid intima media thickness.
Figure. Obesity phenotypes and mean carotid intima media thickness.
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greater than one only for the metabolically unhealthy
phenotypes regardless of whether they were obese or non-
obese [OR=2.8 (95% CI 1.10, 6.93), P=0.0302 for the non-
obese participants; OR=3.26 (95% CI 1.30, 8.03), P=0.0114
for the obese participants, but was not significantly greater
than one for the metabolically healthy obese phenotype
(OR=1.6 [95% CI 0.42, 5.97], P=0.4907, Table 3).
Among the criteria used to describe metabolic health,
systolic and diastolic BP, mean fasting glucose, and HOMA-IR
remained significantly correlated with obesity phenotype and
mean cIMT after adjusting for age and gender. Our findings
from a multivariable survey weighted linear regression model
(which included the obesity phenotypes, age, gender, SBP,
diabetes status, lipids, CRP, servings of fruit and vegetables
per day, physical activity, and smoking status), revealed that
age (P<0.0001), gender (P=0.0039), obesity phenotypes
(P=0.0275), SBP (P=0.0179), and diabetes (P=0.0381)
remained significantly associated with mean cIMT. In further
analysis, using a multivariable analysis model, when we
included obesity and cardiometabolic risk (which takes into
account SBP and diabetes) as separate variables, we found
that cardiometabolic risk (P=0.0159), but not obesity
(P=0.1446), was significantly associated with subclinical
atherosclerosis even after adjusting for age and gender
(Table 4). Metabolically healthy participants had lower mean
cIMT (0.640.01 versus 0.680.01 for metabolically
unhealthy, P=0.0159, Table 4) regardless of whether they
were obese or not. We did not find any significant interaction
effects among the covariates.
Discussion
In Mexican-Americans, cardiometabolic risk has a greater
effect on early atherosclerosis development than BMI alone,
and non-obese but metabolically unhealthy participants had
similar development of subclinical atherosclerosis as their
obese counterparts. This study highlights the importance of
assessing cardiometabolic risk in Mexican-Americans regard-
less of BMI. Carotid IMT has been found to predict future risk
of myocardial infarction and stroke, and a change in cIMT has
been validated as a vascular marker for the progression of
atherosclerosis.29–31 Subclinical atherosclerosis is prevalent
in this asymptomatic community-recruited cohort and is
paralleled by the high prevalence of participants classified as
metabolically unhealthy.
Our study is consistent with a large health-screening
cohort study among Asians that demonstrated that metabol-
ically unhealthy obese participants had similar coronary artery
calcium scores as metabolically unhealthy non-obese partic-
ipants,24 and the authors also suggested that metabolic
health was more important in the development of overt
atherosclerosis than obesity. In a white and black female
cohort, Khan et al similarly demonstrated increased preva-
lence of subclinical atherosclerosis in metabolically abnormal
overweight/obese women compared with their metabolically
benign counterparts.22 In a Hispanic cohort, data from the
San Antonio Heart Study showed that the risk of incident CVD
(median follow-up of 7.4 years) was increased in metabolically
unhealthy normal weight participants but that there was no
gradation of this risk by BMI.32 In other words, CVD risk did
not depend on BMI among these participants and was related
more to their baseline cardiometabolic risk. On the other
hand, incident CVD had a gradation in risk by BMI among
those who were metabolically healthy but obese, and those
participants who were at the higher end of the obesity
spectrum (ie, morbidly obese) were more likely to develop
incident CVD. The authors suggested that these participants
may have transitioned into a metabolically unhealthy pheno-
type. Indeed Appleton et al reported that metabolically
healthy obese individuals are at increased risk of incident
Table 3. Abnormal Carotid Ultrasound Study and Obesity Phenotype
Metabolically Healthy Metabolically Unhealthy
P Value
Healthy Non-Obese Healthy Obese Unhealthy Non-Obese Unhealthy Obese
n=79 n=25 n=149 n=250
Abnormal carotid ultrasound n (%)* n (%)* n (%)* n (%)* F approximation of Rao–Scott
design-adjusted chi-square
test P-value
Yes 11 (15.6) 6 (22.7) 50 (33.8) 89 (37.4) 0.0241
No 68 (84.4) 19 (77.3) 99 (66.2) 161 (62.6)
Weighted OR for abnormal carotid
ultrasound (95% CI)
Reference 1.6 (0.42, 5.97) 2.8 (1.10, 6.93) 3.26 (1.30, 8.03)
Wald chi-square test for parameter
estimates P-values
Reference 0.4907 0.0302 0.0114 Overall: 0.0549
*Unweighted frequencies and weighted percentages.
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diabetes mellitus only if they progress to an unhealthy
phenotype.33 Hence stability of metabolic health in the
metabolically healthy obese phenotype appears to be crucial
for the prevention of CV events.
Only 10% of obese individuals in our cohort were classified
as metabolically healthy compared with the 31.7% prevalence
for the entire US population based on the National Health and
Nutrition Examination Survey (NHANES) data.21 The preva-
lence of the metabolically unhealthy obese phenotype in our
cohort on the other hand, is more than twice that of the
prevalence reported for the NHANES data (48.1% for the
CCHC versus 20.9% for the NHANES data).21 Also worrisome
is that only 17.8% of our cohort was classified as metabol-
ically healthy non-obese compared with the much higher
prevalence estimate of 44.3% for the US population.21 These
findings emphasize not only the obesity disparity among
Mexican-Americans compared with the US population as a
whole but brings to light the finding that among non-obese
Mexican-Americans, there is already a high prevalence of
clustering of cardiometabolic risk factors. Our finding that the
metabolically unhealthy phenotype was associated with age,
male gender, and lower education levels is consistent with
that from other large multi-ethnic studies such as The
Atherosclerosis Risk in Communities Study (ARIC) and
NHANES data,21,34 but in addition we demonstrated that
abdominal adiposity and less intake of fruits and vegetables
are also associated with being metabolically unhealthy.
The World Health Organization (WHO) defines obesity as
“abnormal or excessive fat accumulation in adipose tissue, to
the extent that health is impaired.”35 Visceral adipose tissue
is a metabolically active organ secreting hormones, cytokines,
and growth factors (collectively called adipocytokines or
adipokines),36,37 and is known to be associated with insulin
resistance and its related metabolic abnormalities.38 How-
ever, in the clinical setting, accurate measurement of adipose
tissue is relatively difficult and surrogate measures of
adiposity are used routinely instead. BMI, one such surrogate
measure of adiposity has proven to be relatively reliable,39
and in 2000, the WHO released an updated definition of
overweight and obesity based on BMI criteria.40 BMI,
however, cannot distinguish between fat tissue and lean
tissue, is somewhat arbitrary, and has limitations in predicting
risk in certain ethnic groups.41 BMI generally overestimates
adiposity in persons with more lean body mass, such as
athletes, and underestimates excess adiposity in persons with
less lean body mass. Furthermore, the reference tables used
regarding desirable weight-for-height values were based on
the mortality experience of life insurance policies in the
United States and Canada, a mostly white cohort.42,43 Our
finding that cardiometabolic risk is significantly associated
Table 4. Final Multivariable Linear Regression Model With BMI and Cardiometabolic Risk as 2 Level Categorical Variables with
other Covariates
Variable Parameter Estimate Standard Error t Value P>[t]
Estimated regression coefficients
Intercept 0.260 0.029 9.1 <0.0001
Obese (BMI≥30 kg/m2) 0.023 0.016 1.46 0.1446
Metabolically unhealthy (>2 cardiometabolic risk factors) 0.033 0.014 2.42 0.0156
Age 0.007 0.001 11.38 <0.0001
Gender 0.047 0.015 3.05 0.0025
Adjusted Means Standard Error t Value P>[t]
Adjusted means and standard error based on multivariable regression model
Obese (BMI≥30 kg/m2)
Obese 0.67 0.01 1.46 0.1446
Not obese 0.65 0.01
Metabolically unhealthy (>2 cardiometabolic risk factors)
Metabolically unhealthy 0.68 0.01 2.42 0.0156
Metabolically healthy 0.64 0.01
Gender
Male 0.68 0.01 3.05 0.0025
Female 0.64 0.01
BMI indicates body mass index.
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with subclinical atherosclerosis regardless of BMI, highlights
the limitation of using BMI alone in Mexican-Americans. We
did quantify waist circumference as a measure of central
adiposity and showed that this was different among the
metabolically healthy or unhealthy phenotypes regardless of
whether they were obese or not, but this was not significantly
associated with subclinical atherosclerosis after adjusting for
the other covariates. For future studies, we will look at dual X-
ray absorptiometry (DXA) scans in order to more accurately
quantitate visceral adiposity.
In this study we chose to use the criterion for metabolic
health as defined for the US population from the NHANES
database.21 To date, there is no standardized definition of
obesity phenotypes and metabolic health and there are
over 30 different definitions of metabolic health in the
literature.44 However in one study, 3 definitions of meta-
bolic health were compared and no significant differences
in the relationship of obesity phenotypes to all-cause
mortality were seen regardless of the definition used.44 We
believe that variation across findings among different
studies is not unexpected, but the main tenet that
abnormal metabolic health impacts prevalence of CVD to
a greater extent than BMI alone appears to be consistent.
Consensus is needed if we are to move this concept to
health policy and clinical care.
It has been suggested that obesity phenotypes represent
heritable traits,45 but the genetic factors modulated by
environmental factors mediating metabolic health among
obese persons are not yet defined. On the other hand, one
environmental factor that has been studied in these patients
is level of physical activity. Indeed, it has been suggested that
although body fatness and fitness are strong predictors of
CVD, level of fitness largely negates the adverse effects of
body fatness on CV morbidity and mortality.46–48 In our study,
we did not find physical activity to be significantly associated
with metabolic health regardless of BMI, and this covariate
was not independently associated with subclinical atheroscle-
rosis in a regression analysis after adjusting for other
covariates. This finding is relevant and will need to be
validated in a larger cohort study, but does suggest that
improving fitness may not be a first approach to reducing risk
in Mexican-Americans. On the other hand, meeting recom-
mendations regarding daily intake of fruits and vegetables
was significantly different among those who were metabol-
ically healthy or not in our cohort, and this finding can be
applied when designing public health initiatives to reduce CVD
risk in Mexican-Americans.
There are some factors that may affect our results. This is a
cross-sectional study and cIMT was only evaluated once
without long-term follow-up. However, this is a unique popu-
lation-based sample of randomly selected, apparently healthy,
Mexican-Americans, thus avoiding bias inherent in studies
drawing from clinic populations with mixed ethnicity and
established disease. Although the majority of covariates
evaluated in this study were objectively measured, the use
of questionnaires to assess physical activity and intake of
fruits and vegetables has known disadvantages, particularly
recall bias and measurement error. Nevertheless, the physical
activity and food frequency questionnaires we used in this
study have been validated for this ethnic group.15 Prospective
studies are needed to determine whether targetedmodification
of cardiometabolic risk rather than focusing solely on weight
loss actually translates to reduced cardiac events. Longitudinal
data currently being collected should eventually provide this
answer. In addition, a larger sample size is needed to confirm
our findings as some obesity phenotype categories (particularly
the metabolically healthy obese group) had smaller numbers of
observations. On the other hand, the current study has a
number of strengths, one of which is the very homogeneity of
the cohort studied. To fully understand prevalent risk among
Hispanics, the Hispanic population needs to be disaggregated
into subgroups according to national origins and other
characteristics49 as the paradoxical and conflicting findings
related to CV health among Hispanics may reflect aggregation
error of outcomes data across widely varied subgroups.50
In summary, a substantial gap still remains, particularly
among ethnic groups, in the detection of asymptomatic
individuals who ultimately develop CVD. In the United States,
the Hispanic population has almost doubled between 1990
and 2007 (9% to 15%),51 and is projected to reach 30% by the
year 2050. Of the Hispanics residing in the United States,
Mexican-Americans represent the largest and ethnically dis-
tinct subgroup. Hence, understanding and describing prevalent
disease as well as defining and reducing risk burden in this
minority population are important as the racial/ethnic land-
scape of the United States continues to change. More
research is needed to identify factors that can prevent or
potentially reverse the clustering of metabolic abnormalities in
all categories of BMI. In our cohort, low cardiometabolic risk
was uncommon, so maintenance of metabolic health in the
Mexican-Americans remains a major challenge. The findings in
this study are particularly relevant to future public health
planning as interventions to maintain metabolic health may be
more important goal than focusing on weight loss alone.
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